News

Cognitive behavioral therapy for insomnia effectively treats chronic insomnia, promoting long-term sleep improvement through targeted behavioral strategies.

Moral injuries in health care professionals became an increasing focus during the COVID-19 pandemic, with all the obstacles, uncertainty, and risks of patient care.

More than 20 years later, what have we learned about PTSD, resiliency, and trauma?

Oregon's "Create Resilience" Youth Art Contest celebrates creativity in mental health, showcasing powerful youth submissions that inspire hope and connection.

It is time to redefine treatment resistance, a definition in which we emphasize comprehensive evaluations and personalized approaches for better patient outcomes.

An expert expresses concerns over NRx-100's "expanded access" for ketamine, questioning its safety claims and prioritizing market strategy over patient care.

This article explores the lasting impact of 9/11 on mental health, moral injury, and the role of first responders in crisis situations.

Frank A. Clark, MD, reflects on current state of our country.

Takeda's oveporexton shows promising results in treating narcolepsy type 1, significantly improving symptoms and quality of life in clinical trials.

Christine Yu Moutier, MD, discusses suicide prevention strategies, highlighting risk factors and the importance of culturally competent care for vulnerable populations.

Today is World Suicide Prevention Day. Media training emerges as a vital tool for psychiatrists, enhancing suicide prevention efforts and combating misinformation in mental health.

New research reveals ART12.11, a cannabidiol:tetramethylpyrazine cocrystal, significantly enhances mood regulation, outperforming traditional cannabidiol in treating mood and anxiety disorders.

Explore the complexities of geriatric psychiatry, addressing mental health challenges in aging populations with expert insights and practical strategies.

Alto Neuroscience reveals EEG biomarkers effectively distinguish patients with schizophrenia, enhancing treatment precision and advancing psychiatric research.

What do you do when a patient, who is also a physician, disagrees? A psychiatrist navigates complex mental health challenges, rejecting a bipolar diagnosis while advocating for patient autonomy and addressing stigma in health care.

Tonmya, the first new FDA-approved fibromyalgia treatment in 15 years, shows promise in reducing pain and improving patient outcomes according to newly released data.

FDA approves Amneal Pharmaceuticals' new long-acting injectable risperidone for schizophrenia, enhancing treatment options and potentially patient adherence.

Explore the evolving perceptions and treatments of sexual deviance, particularly pedophilia, from historical views to modern psychiatric approaches.

Alixorexton shows promise as a treatment for narcolepsy type 1, and is the first orexin 2 receptor agonist to demonstrate clinically meaningful and statistically significant impact on wakefulness, cognition, and fatigue with once-daily dosing across a range of doses.

Chatbots pose significant risks for individuals with eating disorders, often promoting harmful behaviors and misinformation while lacking proper safety measures.

Explore the impact of moral injuries on mental health professionals, highlighting the urgent need for attention and support in today's health care landscape.

Psychiatrists confront the challenge of treatment-resistant depression, balancing honesty and compassion while redefining realistic recovery goals for patients.

Cannabis use among older adults surges as they seek relief from pain and anxiety, prompting clinicians to navigate complex treatment challenges.

Postoperative delirium often goes unrecognized, especially in older patients, leading to significant cognitive decline and longer hospital stays.

Explore the profound impact of relationships over achievements as we reflect on legacy and the importance of family connections in later life.

Remembering Robert Jay Lifton, MD

Cognition Therapeutics advances zervimesine phase 2 trial, exploring its potential to slow cognitive decline in Alzheimer disease patients.

Explore the powerful memoirs of Kay Redfield Jamison, offering profound insights into living with bipolar disorder and the complexities of love.

Exploring the prevalence and implications of psychotropic polypharmacy in patients taking clozapine with treatment-resistant schizophrenia.